Artivion

Recent news

• Rating change
  Stifel Maintains Artivion(AORT.US) With Buy Rating, Maintains Target Price $55
  Market Newswire · 2026/3/5
• Rating change
  Lake Street Initiates Artivion(AORT.US) With Buy Rating, Announces Target Price $55
  Market Newswire · 2026/4/8
• Rating change
  Ladenburg Thalmann Upgrades Artivion(AORT.US) to Buy Rating, Raises Target Price to $42
  Market Newswire · 2026/4/10
• Rating change
  Needham Maintains Artivion(AORT.US) With Buy Rating, Maintains Target Price $58
  Market Newswire · 2026/4/20
• Company notice
  GraniteShares YieldBOOST CRCL ETF: CryoLife, Inc. - Name/Symbol Change Option Symbol: CRY New Symbol: AORT
  OCC · 2022/1/20
• Rating change
  CCORF Maintains Artivion(AORT.US) With Buy Rating, Cuts Target Price to $48
  Market Newswire · 2026/2/13
• CCORF Maintains Artivion(AORT.US) With Buy Rating, Maintains Target Price $36
  Market Newswire · 2026/8/4
• Rating change
  Needham Maintains Artivion(AORT.US) With Buy Rating, Maintains Target Price $44
  Market Newswire · 2026/7/20
• Rating change
  Stifel Maintains Artivion(AORT.US) With Buy Rating, Maintains Target Price $45
  Market Newswire · 2026/6/1
• Rating change
  A Quick Look at Today's Ratings for Artivion(AORT.US), With a Forecast Between $41 to $58
  Market Newswire · 2026/2/14
• Lake Street Maintains Artivion(AORT.US) With Buy Rating, Maintains Target Price $45
  Market Newswire · 2026/6/29
• Rating change
  A Quick Look at Today's Ratings for Artivion(AORT.US), With a Forecast Between $38 to $45
  Market Newswire · 2026/8/8
• CCORF Maintains Artivion(AORT.US) With Buy Rating, Raises Target Price to $40
  Market Newswire · 2026/8/18
• CCORF Maintains Artivion(AORT.US) With Buy Rating, Maintains Target Price $39
  Market Newswire · 2026/8/13
• Rating change
  Lake Street Maintains Artivion(AORT.US) With Buy Rating, Maintains Target Price $55
  Market Newswire · 2026/4/7
• Earnings Flash (AORT) Artivion, Inc. Posts Q2 Adjusted EPS $0.13 per Share, Vs. FactSet Est of $0.10
  MT Newswires · 2026/8/7
• Rating change
  CCORF Maintains Artivion(AORT.US) With Buy Rating, Maintains Target Price $48
  Market Newswire · 2026/3/9
• Rating change
  A Quick Look at Today's Ratings for Artivion(AORT.US), With a Forecast Between $36 to $48
  Market Newswire · 2026/5/9
• Rating change
  Analysts Are Bullish on Top Healthcare Stocks: Artivion (AORT), LB Pharmaceuticals, Inc. (LBRX)
  TipRanks · 2026/4/7
• Rating change
  Analysts Offer Insights on Healthcare Companies: Roche Holding AG (OtherRHHVF), Atai Beckley N.V. (ATAI) and Artivion (AORT)
  TipRanks · 2026/3/9

Headlines are aggregated automatically and are not independently verified or edited by our team.